Clinical Trial Update: Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donepezil hydrochloride for cognitive dysfunction in children with Down syndrome has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

Sponsor: Eisai Inc. | Conditions: Down Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-04-19